ASX - By Stock
|
NEU |
Re:
Share Price
|
|
gingerclam
|
9.9K |
4.4M |
13 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
9.9K
|
4.4M
|
13
|
|
ASX - By Stock
|
TLX Biotech |
Re:
'The most exciting new technology that has the most potential to be transformative to medicine' (Novartis CEO)
|
|
gingerclam
|
29 |
18K |
2 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
29
|
18K
|
2
|
|
ASX - By Stock
|
TLX Biotech |
Re:
'The most exciting new technology that has the most potential to be transformative to medicine' (Novartis CEO)
|
|
gingerclam
|
29 |
18K |
8 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
29
|
18K
|
8
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Completes Acquisition of QSAM
|
|
gingerclam
|
5 |
1.7K |
5 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
5
|
1.7K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Annual Report to shareholders
|
|
gingerclam
|
194 |
72K |
16 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
194
|
72K
|
16
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
gingerclam
|
758 |
342K |
9 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
758
|
342K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Annual Report to shareholders
|
|
gingerclam
|
194 |
72K |
7 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
194
|
72K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Annual Report to shareholders
|
|
gingerclam
|
194 |
72K |
13 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
194
|
72K
|
13
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Annual Report to shareholders
|
|
gingerclam
|
194 |
72K |
48 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
194
|
72K
|
48
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Q1 2024 Revenue and Business Update
|
|
gingerclam
|
135 |
49K |
1 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
135
|
49K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Q1 2024 Revenue and Business Update
|
|
gingerclam
|
135 |
49K |
9 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
135
|
49K
|
9
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
gingerclam
|
758 |
342K |
4 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
758
|
342K
|
4
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
gingerclam
|
758 |
342K |
11 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
758
|
342K
|
11
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
gingerclam
|
380 |
113K |
5 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
380
|
113K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
gingerclam
|
9.9K |
4.4M |
9 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
9.9K
|
4.4M
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
gingerclam
|
9.9K |
4.4M |
2 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
9.9K
|
4.4M
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Neuren - where to from here ?
|
|
gingerclam
|
91 |
52K |
42 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
91
|
52K
|
42
|
|
ASX - By Stock
|
NEU |
Re:
Neuren - where to from here ?
|
|
gingerclam
|
91 |
52K |
11 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
91
|
52K
|
11
|
|
ASX - By Stock
|
NEU |
Re:
Neuren - where to from here ?
|
|
gingerclam
|
91 |
52K |
32 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
91
|
52K
|
32
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
gingerclam
|
1.5K |
563K |
8 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
1.5K
|
563K
|
8
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
gingerclam
|
758 |
342K |
6 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
758
|
342K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
gingerclam
|
947 |
473K |
7 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
947
|
473K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
gingerclam
|
947 |
473K |
16 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
947
|
473K
|
16
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
gingerclam
|
947 |
473K |
0 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
947
|
473K
|
0
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
gingerclam
|
758 |
342K |
2 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
758
|
342K
|
2
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
gingerclam
|
758 |
342K |
2 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
758
|
342K
|
2
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
gingerclam
|
758 |
342K |
7 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
758
|
342K
|
7
|
|
ASX - By Stock
|
IPL |
Re:
Ann: Update - Notification of buy-back - IPL
|
|
gingerclam
|
3 |
1.1K |
1 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
3
|
1.1K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
gingerclam
|
1.5K |
563K |
3 |
16/03/24 |
16/03/24 |
ASX - By Stock
|
1.5K
|
563K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
gingerclam
|
1.5K |
563K |
5 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
1.5K
|
563K
|
5
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
gingerclam
|
758 |
342K |
6 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
758
|
342K
|
6
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
gingerclam
|
758 |
342K |
4 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
758
|
342K
|
4
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
gingerclam
|
758 |
342K |
5 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
758
|
342K
|
5
|
|
ASX - By Stock
|
DRR |
Re:
Ann: Change in substantial holding from PPT
|
|
gingerclam
|
1 |
428 |
0 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
1
|
428
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Upcoming Phase 2 Trial Announcement Dates
|
|
gingerclam
|
7 |
3.8K |
4 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
7
|
3.8K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
gingerclam
|
9.9K |
4.4M |
25 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
9.9K
|
4.4M
|
25
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
gingerclam
|
947 |
473K |
5 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
947
|
473K
|
5
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
gingerclam
|
758 |
342K |
2 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
758
|
342K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
gingerclam
|
9.9K |
4.4M |
15 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
9.9K
|
4.4M
|
15
|
|
ASX - By Stock
|
TLX |
Re:
Heidelberg pharma borrow against TLX royalties
|
|
gingerclam
|
4 |
2.2K |
12 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
4
|
2.2K
|
12
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Results webinar
|
|
gingerclam
|
130 |
62K |
9 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
130
|
62K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
gingerclam
|
9.9K |
4.4M |
1 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
9.9K
|
4.4M
|
1
|
|
ASX - By Stock
|
XRO |
Re:
Drifting
|
|
gingerclam
|
20 |
14K |
6 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
20
|
14K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
gingerclam
|
448 |
201K |
2 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
448
|
201K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
gingerclam
|
448 |
201K |
4 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
448
|
201K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
gingerclam
|
448 |
201K |
17 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
448
|
201K
|
17
|
|
ASX - By Stock
|
NEU |
Re:
Ann: DAYBUE net sales US$87.1 million in Q4 2023
|
|
gingerclam
|
79 |
37K |
0 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
79
|
37K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Ann: DAYBUE net sales US$87.1 million in Q4 2023
|
|
gingerclam
|
79 |
37K |
22 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
79
|
37K
|
22
|
|
ASX - By Stock
|
NEU |
Re:
Ann: DAYBUE net sales US$87.1 million in Q4 2023
|
|
gingerclam
|
79 |
37K |
4 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
79
|
37K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Ann: DAYBUE net sales US$87.1 million in Q4 2023
|
|
gingerclam
|
79 |
37K |
0 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
79
|
37K
|
0
|
|